Elekta (EKTAY) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 8 209 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +24.6% close of November 26, 2025
- 1-year change
- +30.8% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- +21% closing prices, October 2, 2026 to November 5, 2026
Company Description
Elekta (OTC: EKTAY) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $2.4B.
EKTAY has gained 30.8% over the past year. The last closing price was $6.16.
This page collects what Stock Titan holds for EKTAY, including price data, latest news, and short interest trends.
Stock Performance
Elekta (EKTAY) closed at $6.16 on November 5, 2026. Over the past 12 months, the price has gained 30.8%.
EKTAY Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Elekta has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings. View all EKTAY news →
SEC Filings
Short Interest History
Short interest in Elekta (EKTAY) currently stands at 191 shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since November 2025, short interest has decreased by 97.1%.
Days to Cover History
Days to cover for Elekta (EKTAY) currently stands at 1.0 days, down 51% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.2 days.
EKTAY Company Profile & Sector Positioning
Elekta (EKTAY) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing EKTAY often look at related companies in the same sector, including GN Store Nord A/S (GNNDY), Elekta (EKTAF), Ambu A S (AMBBY), Getinge AB (GNGBY), and Getinge AB (GNGBF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EKTAY's relative position within its industry.